Samantha Dupre
Primary Care · Macon, GANPI 1700584703
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 93 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 16.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $1,291 and has fallen 68.0% since, to $413 in 2025.
Across 93 payments — averaging $20.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$325
- AstraZeneca$275
- Lilly USA, LLC$202
- GSK$136
- Novo Nordisk$121
- Bayer$108
- plus $754 from 20 others
What the payments were for
- Food & beverage$1,921100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 15 | $325 |
| AstraZeneca | 13 | $275 |
| Lilly USA, LLC | 13 | $202 |
| GSK | 2 | $136 |
| Novo Nordisk | 6 | $121 |
| Bayer | 5 | $108 |
| Pfizer | 5 | $85 |
| Radius Health, Inc. | 3 | $84 |
| Exact Sciences | 4 | $73 |
| Sumitomo Pharma America, Inc. | 3 | $64 |
| Sanofi-aventis U.S. LLC | 3 | $59 |
| Antares Pharma, Inc. | 2 | $39 |
| Amneal Pharmaceuticals LLC | 2 | $37 |
| Merck | 2 | $35 |
| Boehringer Ingelheim | 2 | $32 |
| Kowa Pharmaceuticals America, Inc. | 2 | $30 |
| Dexcom, Inc. | 2 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $29 |
| Vanda Pharmaceuticals Inc. | 1 | $23 |
| Abbott | 1 | $23 |
| Mannkind Corporation | 1 | $22 |
| Amgen | 1 | $19 |
| Esperion Therapeutics, Inc. | 1 | $19 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $17 |
| Tolmar, Inc. | 1 | $17 |
| Idorsia Pharmaceuticals US Inc | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AREXVY$125
How this compares
$1,921 in reported general payments places this provider in the 75th percentile of 235 primary care providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 65 | $68,410 |
| OzempicSemaglutide | 13 | $14,476 |
| SynthroidLevothyroxine Sodium | 21 | $1,217 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 46 | $1,172 |
| Gabapentin | 56 | $587 |
| Losartan Potassium | 57 | $424 |
| Amlodipine Besylate | 109 | $417 |
| Levothyroxine Sodium | 38 | $398 |
| Omeprazole | 20 | $371 |
| Tizanidine Hcl | 39 | $352 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 36 | $346 |
| Pantoprazole Sodium | 25 | $319 |
| Esomeprazole Magnesium | 14 | $287 |
| Lisinopril | 52 | $279 |
| Atorvastatin Calcium | 48 | $258 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $32 | $68,41065 claims |
| Novo NordiskOzempic | $121 | $14,47613 claims |
| AbbVieSynthroid | $325 | $1,21721 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $37 | $39838 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 235 primary care providers in Georgia.
Other primary care in Macon
- Lauren LambethMacon$4K
- Shannon MitchellMacon$3K
- Morgan EnnisMacon$2K
- Garry MichaelMacon$2K
- Pamela TurkDouglas$15K
- Morgan JonesLawrenceville$14K
- Jessi HaleColumbus$13K
- Meredith CarrAugusta$12K
- Ashtyn ZaryckiSavannah$12K
- Zanetta BryantNewnan$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.